Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice
2021 · Acta Pharmaceutica Sinica B · 100 citations
https://doi.org/10.1016/j.apsb.2021.03.038
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
684
Citations
13
h-index
15
i10-index
Yangmeng Wang is an academic researcher from Translational Research in Oncology. The author has contributed to research in topics: Adipose Tissue and Metabolism & Diet and metabolism studies & Metabolism, Diabetes, and Cancer. The author has an h-index of 13, co-authored 28 publications.
https://doi.org/10.1016/j.apsb.2021.03.038
https://doi.org/10.1016/j.omtn.2022.08.036
Click to start Chat